| Symbol | ATRC |
|---|---|
| Name | ATRICURE, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 7555 INNOVATION WAY, MASON, Ohio, 45040, United States |
| Telephone | +1 513 755-4100 |
| Fax | — |
| — | |
| Website | https://www.atricure.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. Additional info from NASDAQ: |
New Form DEFA14A - AtriCure, Inc. <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001323885-26-000011 <b>Size:</b> 1 MB
Read moreNew Form DEF 14A - AtriCure, Inc. <b>Filed:</b> 2026-04-06 <b>AccNo:</b> 0001323885-26-000010 <b>Size:</b> 4 MB
Read moreNew Form SCHEDULE 13G/A - AtriCure, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-000781 <b>Size:</b> 7 KB
Read more📋 VINAYAK DORAISWAMY (Officer) plans to sell 5K shares of ATRICURE, INC. (at $29.83 each, total $149K) Filed: Mar 12, 2026 | ID: 002553
Read moreDirector WHITE ROBERT S. 🟡 adjusted position in 0 shares (1 derivative) of AtriCure, Inc. (ATRC) at $14.99 Transaction Date: Mar 10, 2026 | Filing ID: 000002
Read moreDirector CARREL MICHAEL H 🔴 sold 6.0K shares of AtriCure, Inc. (ATRC) Transaction Date: Mar 06, 2026 | Filing ID: 000004
Read moreNoznesky Justin J 🟡 adjusted position in 27.6K shares of AtriCure, Inc. (ATRC) at $31.26 Transaction Date: Mar 01, 2026 | Filing ID: 000002
Read morePrivitera Salvatore 🟡 adjusted position in 32.5K shares of AtriCure, Inc. (ATRC) at $31.26 Transaction Date: Mar 01, 2026 | Filing ID: 000002
Read moreDoraiswamy Vinayak 🟡 adjusted position in 30.0K shares of AtriCure, Inc. (ATRC) at $31.26 Transaction Date: Mar 01, 2026 | Filing ID: 000002
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT05280093 | HEAL-IST IDE Trial | Na | Inappropriate Sinus Tachycardia | Active_Not_Recruiting | 2022-05-31 | 2028-02-01 | ClinicalTrials.gov |
| NCT05393180 | CONVERGE Post-Approval Study (PAS) | Na | Chronic Atrial Fibrillation | Active_Not_Recruiting | 2022-04-13 | 2028-11-21 | ClinicalTrials.gov |
| NCT04468334 | aMAZE Trial Continued Access Protocol | Na | Atrial Fibrillation | Completed | 2020-03-09 | 2023-04-24 | ClinicalTrials.gov |
| NCT05111015 | Tracking Results of Ablations to Combat AF Registry Generation 2 | — | Atrial Fibrillation | Recruiting | 2013-02-01 | 2030-01-01 | ClinicalTrials.gov |
| NCT00566787 | Concomitant Treatment of Permanent Atrial Fibrillation | Phase3 | Atrial Fibrillation | Completed | 2005-01-01 | 2010-11-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | Drug | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Atricure CryoSPHERE MAX Probe | DEVICE | Approved | Post-operative Pain Management | RECRUITING | NCT07281118 |
| Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System | DEVICE | Approved | Post Operative Atrial Fibrillation | RECRUITING | NCT06989775 |
| cryoablation | DEVICE | Preclinical | Amputation | RECRUITING | NCT06908538 |
| Atricure's crysoSPHERE probe | DEVICE | Approved | Pain, Postoperative | RECRUITING | NCT06384664 |
| Catheter ablation | PROCEDURE | Approved | Atrial Fibrillation | WITHDRAWN | NCT06182566 |
| Convergent ablation | PROCEDURE | Approved | Atrial Fibrillation | WITHDRAWN | NCT06182566 |
| Standard Endocardial Catheter Ablation | PROCEDURE | Approved | Persistent Atrial Fibrillation | RECRUITING | NCT06165510 |
| Epicardial AF ablation using AtriCure EPi-Sense-AF Guided Coagulation System with Left Atrial Appendage Exclusion using the AtriCure LARIAT Suture Delivery Device. | DEVICE | Approved | Persistent Atrial Fibrillation | RECRUITING | NCT06165510 |
| Opioids (oxycodone with prolonged discharge 10 mg PO every 12 hours and oxycodone 5 mg every 6 hours, as needed) | DRUG | Approved | Pectus Excavatum | COMPLETED | NCT05731973 |
| Intercostal nerve block (single shot bupivacaine (1.25 mg/ml)) | DRUG | Approved | Pectus Excavatum | COMPLETED | NCT05731973 |
| Thoracic epidural analgesia (continuous infusion with sufentanyl (1 µg/ml) and bupivacaine (1.25 mg/ml)) | DRUG | Approved | Pectus Excavatum | COMPLETED | NCT05731973 |
| Intercostal nerve cryoablation | PROCEDURE | Approved | Pectus Excavatum | COMPLETED | NCT05731973 |
| AtriClip LAA Exclusion System | DEVICE | Approved | Ischemic Stroke | ACTIVE_NOT_RECRUITING | NCT05478304 |
| Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF | DEVICE | Approved | Chronic Atrial Fibrillation | ACTIVE_NOT_RECRUITING | NCT05393180 |
| Standard of Care Pain Control | OTHER | Approved | Cryotherapy Effect | ACTIVE_NOT_RECRUITING | NCT05348447 |
| cryoanalgesia | DEVICE | Approved | Cryotherapy Effect | ACTIVE_NOT_RECRUITING | NCT05348447 |
| AtriCure ISOLATOR Synergy Surgical Ablation System | DEVICE | Approved | Inappropriate Sinus Tachycardia | ACTIVE_NOT_RECRUITING | NCT05280093 |
| Patient-controlled analgesia (PCA) | DRUG | Phase PHASE4 | Pain, Postoperative | COMPLETED | NCT05144828 |
| Intercostal Nerve Cryoablation | DEVICE | Phase PHASE4 | Pain, Postoperative | COMPLETED | NCT05144828 |
| AtriCure LAA Exclusion Procedures | DEVICE | Preclinical | Atrial Fibrillation | RECRUITING | NCT05111015 |
| AtriCure Hybrid Totally Thoracoscopic Ablation Procedures | DEVICE | Preclinical | Atrial Fibrillation | RECRUITING | NCT05111015 |
| Hybrid (Convergent) Ablation Procedures | DEVICE | Preclinical | Atrial Fibrillation | RECRUITING | NCT05111015 |
| Open Concomitant Surgical Ablation Procedures | DEVICE | Preclinical | Atrial Fibrillation | RECRUITING | NCT05111015 |
| AtriCure Cryo Nerve Block (cryoNB) Device Family | DEVICE | Preclinical | Post Operative Pain | RECRUITING | NCT05110989 |
| AtriCure Commercially Available Devices | DEVICE | Preclinical | Inappropriate Sinus Tachycardia | RECRUITING | NCT05107635 |
| AtriClip | DEVICE | Approved | Left Atrial Appendage Absent | COMPLETED | NCT05101993 |
| Convergence Of Epicardial And Endocardial RF Ablation | DEVICE | Approved | Atrial Fibrillation | WITHDRAWN | NCT04239534 |
| exclusion of the left atrial appendage | DEVICE | Preclinical | Left Atrial Appendage Ligation | COMPLETED | NCT03759418 |
| Percutaneous catheter ablation | PROCEDURE | Approved | Atrial Fibrillation | RECRUITING | NCT03737929 |
| Hybrid ablation | PROCEDURE | Approved | Atrial Fibrillation | RECRUITING | NCT03737929 |
| AtriCure CryoICE & AtriClip LAA Exclusion | DEVICE | Approved | Atrial Fibrillation (AF) | ACTIVE_NOT_RECRUITING | NCT03732794 |
| Intercostal Cryoanalgesia | PROCEDURE | Approved | Chronic Post-thoracotomy Pain | UNKNOWN | NCT03538340 |
| Thoracic Epidural | PROCEDURE | Approved | Chronic Post-thoracotomy Pain | UNKNOWN | NCT03538340 |
| Standard of Care | PROCEDURE | Approved | Pain, Postoperative | RECRUITING | NCT06384664 |
| Cryoanalgesia | DEVICE | Approved | Pain | COMPLETED | NCT02922153 |
| Anticoagulation Therapy | DRUG | Phase PHASE4 | Post-Operative Atrial Fibrillation | COMPLETED | NCT02701062 |
| AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems | DEVICE | Phase PHASE4 | Post-Operative Atrial Fibrillation | COMPLETED | NCT02701062 |
| Repeated Endocardial ablation(s) | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT02695277 |
| Endocardial Ablation with Catheter | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT02695277 |
| AtriClip® PRO LAA Exclusion System | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT02695277 |
| Standard Endocardial Ablation with Catheter | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT02695277 |
| Pulmonary Vein Isolation | DEVICE | Approved | Atrial Fibrillation | UNKNOWN | NCT02513797 |
| LARIAT + PVI | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT04468334 |
| AtriCure Bipolar System and AtriClip® PRO LAA Exclusion System, Endocardial Ablation | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT02393885 |
| LARIAT RS Suture Delivery Device | DEVICE | Approved | Atrial Appendage | COMPLETED | NCT02059707 |
| AtriClip LAA Exclusion Device | DEVICE | Phase PHASE1 | Atrial Fibrillation | COMPLETED | NCT01997905 |
| Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering | DEVICE | Approved | Persistent Atrial Fibrillation | COMPLETED | NCT01984346 |
| AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax | DEVICE | Approved | Persistent Atrial Fibrillation | COMPLETED | NCT01984346 |
| LARIAT Suture Delivery Device | DEVICE | Approved | Atrial Appendage | COMPLETED | NCT01983605 |
| Synergy Ablation System | DEVICE | Approved | Persistent Atrial Fibrillation | COMPLETED | NCT01694563 |
| LARIAT Suture Delivery Device and Accessories | DEVICE | Phase PHASE4 | Atrial Fibrillation | WITHDRAWN | NCT01680757 |
| Ablation procedure staged catheter ablation | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT01661205 |
| Surgical Ablation | DEVICE | Preclinical | Atrial Fibrillation | COMPLETED | NCT05089877 |
| Catheter Ablation | PROCEDURE | Approved | Atrial Fibrillation | COMPLETED | NCT00662701 |
| Hybrid: AtriCure Bipolar System & EP ablation procedure | DEVICE | Approved | Persistent Atrial Fibrillation | COMPLETED | NCT01246466 |
| Totally Thoracoscopic Maze | PROCEDURE | Preclinical | Atrial Fibrillation Ablation | COMPLETED | NCT01034852 |
| AtriCure LAA Exclusion System | DEVICE | Phase PHASE2 | Left Atrial Appendage Exclusion | COMPLETED | NCT00779857 |
| Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System | DEVICE | Phase PHASE3 | Atrial Fibrillation | COMPLETED | NCT00566787 |
| Surgical Ablation using the AtriCure Bipolar System | DEVICE | Phase PHASE2 | Atrial Fibrillation | UNKNOWN | NCT00566176 |
| AtriCure Bipolar System | DEVICE | Approved | Atrial Fibrillation | COMPLETED | NCT02695277 |